• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质性肺疾病和非过敏性哮喘患者支气管肺泡灌洗的细胞因子谱

Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma.

作者信息

Greif Lenarčič Dana, Bidovec Stojković Urska, Kristanc Pia, Kopač Peter, Malovrh Mateja Marc, Kern Izidor, Osolnik Katarina, Korošec Peter

机构信息

University Clinic of Respiratory and Allergic Diseases, 4204 Golnik, Slovenia.

Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.

出版信息

Int J Mol Sci. 2025 Jul 16;26(14):6831. doi: 10.3390/ijms26146831.

DOI:10.3390/ijms26146831
PMID:40725075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12295261/
Abstract

Diagnosing and prognosing immune-mediated airway diseases, like hypersensitivity pneumonitis (HP) and sarcoidosis, is complicated due to their overlapping symptoms and the lack of definitive biomarkers. Hence, we wanted to compare bronchoalveolar lavage (BAL) cytokine and chemokine profiles from 92 patients with different immune-mediated and inflammatory airway diseases, namely, HP, sarcoidosis, non-allergic asthma, amiodarone lung, and EGPA. We also compared pulmonary function parameters, BAL's cellularity, and lymphocyte immunophenotypes. We found significant differences across all measured lung functions (VC, VC%, FEV1, FEV1%, and Tiff%) and in the number of macrophages, lymphocytes, neutrophils, and eosinophils. Furthermore, we showed significant differences in CD4, CD8, and CD4/8 across all included ILDs and OLDs; however, no significant differences were found in CD3, CD19, NK, or NKT. We identified nine biomarkers (IL-1β, IL-6, IL-8, IL-13, VEGF, angiogenin, C4a, RANTES, and MCP-1) that significantly differ in the BAL of patients with HP and sarcoidosis and showed that RANTES and IL-6 are associated with fibrotic outcome. We have demonstrated that interstitial and obstructive lung diseases differ in cytokine and cellular lung imprint, which may, in the future, enable the determination of the disease subtype and thus the identification of targets for the treatment of individuals or subgroups within diseases.

摘要

诊断和预测免疫介导的气道疾病,如过敏性肺炎(HP)和结节病,由于其症状重叠且缺乏明确的生物标志物而变得复杂。因此,我们想比较92例患有不同免疫介导和炎性气道疾病(即HP、结节病、非过敏性哮喘、胺碘酮肺和嗜酸性肉芽肿性多血管炎)患者的支气管肺泡灌洗(BAL)细胞因子和趋化因子谱。我们还比较了肺功能参数、BAL的细胞成分和淋巴细胞免疫表型。我们发现所有测量的肺功能(肺活量、肺活量百分比、第1秒用力呼气容积、第1秒用力呼气容积百分比和 Tiff 指数)以及巨噬细胞、淋巴细胞、中性粒细胞和嗜酸性粒细胞数量均存在显著差异。此外,我们发现所有纳入的间质性肺疾病(ILDs)和阻塞性肺疾病(OLDs)在CD4、CD8和CD4/8方面存在显著差异;然而,在CD3、CD19、自然杀伤细胞(NK)或自然杀伤T细胞(NKT)方面未发现显著差异。我们确定了9种生物标志物(白细胞介素-1β、白细胞介素-6、白细胞介素-8、白细胞介素-13、血管内皮生长因子、血管生成素、C4a、调节活化正常T细胞表达和分泌的趋化因子(RANTES)和单核细胞趋化蛋白-1),它们在HP和结节病患者的BAL中存在显著差异,并表明RANTES和白细胞介素-6与纤维化结局相关。我们已经证明,间质性和阻塞性肺疾病在细胞因子和细胞肺印记方面存在差异,这在未来可能有助于确定疾病亚型,从而识别疾病中个体或亚组的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/c55858aa3877/ijms-26-06831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/4d625c354dff/ijms-26-06831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/1966b43b7716/ijms-26-06831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/4103fc87df3b/ijms-26-06831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/c55858aa3877/ijms-26-06831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/4d625c354dff/ijms-26-06831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/1966b43b7716/ijms-26-06831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/4103fc87df3b/ijms-26-06831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21f9/12295261/c55858aa3877/ijms-26-06831-g004.jpg

相似文献

1
Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma.间质性肺疾病和非过敏性哮喘患者支气管肺泡灌洗的细胞因子谱
Int J Mol Sci. 2025 Jul 16;26(14):6831. doi: 10.3390/ijms26146831.
2
Progesterone amplifies allergic inflammation and airway pathology in association with higher lung ILC2 responses.孕激素增强过敏炎症和气道病理,与肺 ILC2 反应增强相关。
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 1;327(1):L65-L78. doi: 10.1152/ajplung.00207.2023. Epub 2024 Apr 23.
3
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
4
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
5
Anti-IL5 therapies for asthma.用于哮喘的抗白细胞介素-5疗法。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
6
Lung proinflammatory microRNA and cytokine expression in a mouse model of allergic inflammation: role of sex chromosome complement and gonadal hormones.在过敏性炎症的小鼠模型中肺部促炎 microRNA 和细胞因子的表达:性染色体组成和性腺激素的作用。
Physiol Genomics. 2024 Feb 1;56(2):179-193. doi: 10.1152/physiolgenomics.00049.2023. Epub 2023 Dec 4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2013 Dec 23(12):CD009530. doi: 10.1002/14651858.CD009530.pub2.
9
The clinical meaning of the UIP pattern in fibrotic hypersensitivity pneumonitis on cryobiopsy: A multicentre retrospective study.冷冻活检中纤维化性过敏性肺炎的UIP模式的临床意义:一项多中心回顾性研究。
Pulmonology. 2025 Dec 31;31(1):2425503. doi: 10.1080/25310429.2024.2425503. Epub 2024 Nov 12.
10
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.

本文引用的文献

1
Insights on immune profile, pathogenesis and differential diagnosis of hypersensitivity pneumonitis and pulmonary sarcoidosis-A holistic review and bibliometric analysis.
Respir Investig. 2025 May;63(3):346-357. doi: 10.1016/j.resinv.2025.03.002. Epub 2025 Mar 13.
2
Sarcoidosis: molecular mechanisms and therapeutic strategies.结节病:分子机制与治疗策略
Mol Biomed. 2025 Feb 5;6(1):6. doi: 10.1186/s43556-025-00244-z.
3
Highly multiplexed cytokine analysis of bronchoalveolar lavage and plasma reveals age-related dynamics and correlates of inflammation in children.
Mucosal Immunol. 2025 Apr;18(2):380-389. doi: 10.1016/j.mucimm.2024.12.008. Epub 2024 Dec 13.
4
Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.非 2 型严重哮喘的研究进展:从分子认识到新的治疗策略。
Eur Respir J. 2024 Aug 15;64(2). doi: 10.1183/13993003.00826-2023. Print 2024 Aug.
5
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.循证指南:嗜酸性肉芽肿性多血管炎的诊断与管理。
Nat Rev Rheumatol. 2023 Jun;19(6):378-393. doi: 10.1038/s41584-023-00958-w. Epub 2023 May 9.
6
Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.支气管肺泡灌洗细胞计数和淋巴细胞增多是纤维化性过敏性肺炎与特发性肺纤维化之间的重要鉴别指标。
Diagnostics (Basel). 2023 Mar 1;13(5):935. doi: 10.3390/diagnostics13050935.
7
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study.间质性肺疾病对肺泡细胞外囊泡谱的影响:一项多中心研究。
Int J Mol Sci. 2023 Feb 17;24(4):4071. doi: 10.3390/ijms24044071.
8
Immunopathological Mechanisms of Bird-Related Hypersensitivity Pneumonitis.与鸟类相关的变应性肺炎的免疫病理机制。
Int J Mol Sci. 2023 Feb 2;24(3):2884. doi: 10.3390/ijms24032884.
9
Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study.特发性肺泡蛋白沉积症、结缔组织病相关间质性肺疾病和特发性间质性肺炎之间的炎症和纤维化途径是否存在差异?一项单中心初步研究。
Int J Mol Sci. 2022 Dec 2;23(23):15205. doi: 10.3390/ijms232315205.
10
Eosinophilic granulomatosis with polyangiitis: A review.嗜酸性肉芽肿伴多血管炎:综述。
Autoimmun Rev. 2023 Jan;22(1):103219. doi: 10.1016/j.autrev.2022.103219. Epub 2022 Oct 22.